Open AccessDouble-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation
Author(s) -
Julia Bartley,
Audrey Brown,
R A Elton,
David T. Baird
Publication year - 2001
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/16.10.2098
Subject(s) - mifepristone , misoprostol , medicine , gestation , abortion , obstetrics , gynecology , hormone antagonist , abortifacient , pregnancy , endocrine system , endocrinology , biology , hormone , genetics
Gemeprost and misoprostol are two of the most widely used prostaglandins in combination with mifepristone for medical abortion in early pregnancy. However, the efficacy and side-effects of those two drugs given vaginally have not been assessed in a randomized trial.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom